Simonis, Gregor
Schatz, Ulrike
Article History
Accepted: 5 March 2025
First Online: 2 April 2025
Declarations
:
: G. Simonis has received speaker honoraria from Novo Nordisk, Amgen, Boehringer Ingelheim, Astra Zeneca, and Novartis and study honoraria from Novo Nordisk and Novartis. U. Schatz has received speaker and/or consulting honoraria from Amgen, Astra Zeneca, Boehringer Ingelheim, Daiichi Sankyo, Lilly, Novartis, Novo Nordisk, Sanofi Aventis, and Synlab Holding GmbH. U. Schatz and G. Simonis chair the annual meeting “Diabetes und Herz” held in Dresden.
: This article does not contain any studies with human participants or animals performed by any of the authors.